1492 Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

1492 Capital Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-74,265	Closed	-$409K	–	127
2022 Q3	$409K	Sell	74,265 -24	-0%	-$133	0.29%	78
2022 Q2	$271K	Buy	74,289 +357	+0.5%	+$1.69K	0.18%	87
2022 Q1	$447K	Sell	73,932 -932	-1%	-$5.68K	0.24%	79
2021 Q4	$631K	Buy	+74,864	New	+$654K	0.31%	71

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

1492 Capital Management's APEN Position: Q4 2022 in Review

1492 Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 74,265 shares — an estimated $409K sold.

1492 Capital Management first reported a position in APEN in Q4 2021 and held it in 4 quarters. The position peaked at $631K in Q4 2021. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

1492 Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
1492 Capital Management sold 74,265 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $409K.
1492 Capital Management first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 4 quarters.
1492 Capital Management's Apollo Endosurgery, Inc. position peaked at $631K in Q4 2021.
81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on 1492 Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.